We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

156 hedge funds and large institutions have $819M invested in Natus Medical Inc in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 50 increasing their positions, 65 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more capital invested

Capital invested by funds: $633M → $819M (+$186M)

4% less funds holding

Funds holding: 163156 (-7)

22% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 23

23% less repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 65

61% less call options, than puts

Call options by funds: $622K | Put options by funds: $1.6M

Holders
156
Holders Change
-7
Holders Change %
-4.29%
% of All Funds
2.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
50
Reduced
65
Closed
23
Calls
$622K
Puts
$1.6M
Net Calls
-$981K
Net Calls Change
+$404K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$166M +$19.5M +760,433 +13%
Vanguard Group
2
Vanguard Group
Pennsylvania
$73.7M +$2.31M +90,031 +3%
Victory Capital Management
3
Victory Capital Management
Texas
$51.1M -$859K -33,525 -2%
Wells Fargo
4
Wells Fargo
California
$38M +$5.37M +209,492 +16%
State Street
5
State Street
Massachusetts
$34.3M +$582K +22,696 +2%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$30.8M -$911K -35,548 -3%
N
7
Nuveen
North Carolina
$30.8M +$1.66M +64,643 +6%
Janus Henderson Group
8
Janus Henderson Group
United Kingdom
$29.2M -$7.33K -286 -0%
Wellington Management Group
9
Wellington Management Group
Massachusetts
$21.2M -$1.66M -64,733 -7%
Ameriprise
10
Ameriprise
Minnesota
$18.5M +$11.9M +463,198 +179%
Invesco
11
Invesco
Georgia
$16M -$2.79M -108,903 -15%
Renaissance Technologies
12
Renaissance Technologies
New York
$15.2M -$5.97M -232,800 -28%
Goldman Sachs
13
Goldman Sachs
New York
$14.8M -$3.14M -122,410 -18%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$14.3M +$1.52M +59,182 +12%
Northern Trust
15
Northern Trust
Illinois
$12.6M -$2.6M -101,604 -17%
Impax Asset Management Group
16
Impax Asset Management Group
United Kingdom
$12.1M
Arrowstreet Capital
17
Arrowstreet Capital
Massachusetts
$12M
Diamond Hill Capital Management
18
Diamond Hill Capital Management
Ohio
$11.3M -$62.2K -2,427 -0.5%
Fisher Asset Management
19
Fisher Asset Management
Washington
$11.2M -$76.6K -2,986 -0.7%
Russell Investments Group
20
Russell Investments Group
United Kingdom
$11.2M +$1.11M +43,309 +11%
Norges Bank
21
Norges Bank
Norway
$10.2M -$676K -26,358 -6%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$9.06M -$13.3K -519 -0.1%
JP Morgan Chase
23
JP Morgan Chase
New York
$8.88M +$873K +34,048 +11%
FAM
24
Fenimore Asset Management
New York
$8.73M -$1.39M -54,045 -14%
Prudential Financial
25
Prudential Financial
New Jersey
$8.08M +$1M +39,147 +14%

NTUS Hedge Fund Activity: Q1 2021 in Review

156 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q1 2021, worth a combined $819M — up 29% from $633M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of NTUS and 18 opened new positions — a net loss of 5 holders — while 65 trimmed existing stakes and 50 added.

The largest buyer was BlackRock, adding an estimated $19.5M. The largest seller was Renaissance Technologies, cutting an estimated $5.97M.

  • 156 institutional investors held Natus Medical Inc (NTUS) as of Q1 2021, down from 163 in Q4 2020.
  • Funds reported $819M of Natus Medical Inc stock for Q1 2021, up 29% quarter-over-quarter.
  • 18 funds opened new Natus Medical Inc positions in Q1 2021 and 23 closed out, a net change of -5 holders.
  • The largest Natus Medical Inc buyer in Q1 2021 was BlackRock, an estimated $19.5M added.
  • The largest Natus Medical Inc seller in Q1 2021 was Renaissance Technologies, an estimated $5.97M sold.

Based on aggregated 13F filings for Q1 2021.